Esophageal Diseases  >>  capecitabine 
Welcome,         Profile    Billing    Logout  

1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
capecitabine / Generic mfg.
SCOPE2, NCT02741856 / 2015-001740-11: Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation

Recruiting
2/3
584
Europe
Carboplatin, Paclitaxel, Cisplatin, Capecitabine, Radiotherapy
Lisette Nixon, Cancer Research UK
Oesophageal Cancer
04/21
04/23

Download Options